Measurement of whole blood sirolimus by an HPLC assay using solid-phase extraction and UV detection

Therapeutic Drug Monitoring

Volumn 24, Issue 6, 2002, Pages 751-756

  Connor, Erin ^a   Sakamoto, Masayuki ^a   Fujikawa, Kenichi ^a   Law, Terence ^a   Rifai, Nader ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

HPLC assay; Sirolimus; Solid phase extraction

Indexed keywords

32 DESMETHOXYRAPAMYCIN; AMIKACIN; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BARBITURIC ACID; CARBAMAZEPINE; CHLORAMPHENICOL; CLOMIPRAMINE; CLONAZEPAM; CYCLOSPORIN; DECEPINE; DOXEPIN; ETHOSUXIMIDE; FELBAMATE; GENTAMICIN; LIDOCAINE; MAPROTILINE; METHYLPHENOBARBITAL; NORTRIPTYLINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROCAINAMIDE; PROTRIPTYLINE; QUINIDINE; RAPAMYCIN; TACROLIMUS; TOBRAMYCIN; TRIMIPRAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IMMUNOSUPPRESSIVE AGENT;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION; BLOOD; DRUG MONITORING; METHODOLOGY; SOLUTION AND SOLUBILITY; STANDARD; ULTRAVIOLET SPECTROPHOTOMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; IMMUNOSUPPRESSIVE AGENTS; INDICATORS AND REAGENTS; REFERENCE STANDARDS; SIROLIMUS; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0036891335     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200212000-00012     Document Type: Article

References (10)

1. Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo) 1975;28:727-732.
2. Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975;28: 721-726.
3. Henderson DJ, Naya I, Bundick RV, et al. Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production. Immunology 1991;73:316-321.
4. Napoli KL, Taylor PJ. From beach to bedside: History of the development of sirolimus. Ther Drug Monit 2001;23:559-586.
5. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
6. Napoli KL, Kahan BD. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection. Clin Chem 1996;42:1943-1948.
7. Yatscoff RW, Faraci C, Bolingbroke P. Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography. Ther Drug Monit 1992;14:138-141.
8. French DC, Saltzgueber M, Hicks DR, et al. HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus. Clin Chem 2001;47:1316-1319.
9. Taylor PJ, Johnson AG. Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatographyelectrospray tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 1998;718:251-257.
10. Volosov A, Napoli KL, Soldin SJ. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry. Clin Biochem 2001;34: 285-290.